Atrion Corp
ATRIDelisted Aug 21, 2024- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0000701288
Atrion Corp was delisted on Aug 21, 2024; its insiders filed their last Form 4 on Aug 21, 2024; 143 institutions reported holding it in 13F filings for Q2 2024, worth $544.8M in total; no superinvestor held it.
13F holders, Q2 2024
Institutional positions in Atrion Corp as of Jun 30, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
ATRI is no longer listed, so this page shows Q2 2024. 13F filings for later quarters list far fewer holders.
- Institutional holders
- 143
- +30 vs. Q1 2024
- Shares held
- 1.20M
- −50.6K (−4.0%) vs. Q1 2024
- Total value
- $544.8M
- −$36.7M (−6.3%) vs. Q1 2024
- New holders
- 46
- 34 more added
- Sold out
- 16
- 42 more reduced
1 institution that held it in Q1 2024 haven't filed for Q2 2024 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ATRI on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 1 | $460 |
| Q1 2026 | 1 | $460 |
| Q4 2025 | 1 | $460 |
| Q3 2025 | 1 | $460 |
| Q2 2025 | 1 | $460 |
| Q1 2025 | 1 | $460 |
| Q4 2024 | 1 | $460 |
| Q3 2024 | 1 | $460 |
| Q2 2024 | 143 | $544.8M |
| Q1 2024 | 114 | $583.3M |
| Q4 2023 | 112 | $438.0M |
| Q3 2023 | 109 | $470.7M |
| Q2 2023 | 119 | $649.0M |
| Q1 2023 | 123 | $722.4M |
| Q4 2022 | 113 | $635.0M |
| Q3 2022 | 117 | $649.1M |
| Q2 2022 | 127 | $733.5M |
| Q1 2022 | 130 | $839.9M |
| Q4 2021 | 124 | $829.9M |
| Q3 2021 | 128 | $821.9M |
| Q2 2021 | 126 | $726.3M |
| Q1 2021 | 122 | $763.1M |
Institutions, Q2 2024
Shares, value and share of portfolio for each institution holding Atrion Corp; share changes are against Q1 2024.